Jellagen
Develops and manufactures medical-grade Collagen Type 0 derived from jellyfish for bioprinting and tissue engineering, addressing risks of traditional mammalian sources.
- CEO / Founder
- Dr Andrew Spragg
- Team Size
- <50 employees
- Stage
- Active
- Total Funding
- £6.5M
- Latest Round
- Debt
- Key Investors
- dbw investments (3) ltd, Cardiff city region, MedCity Angels
Technology & Products
Key Products
Collagen Type 0 biomaterials; Cell culture scaffolds; Bioprinting hydrogels; Wound care materials
Technological Advantage
Evolutionary ancient collagen (Type 0) is compatible with a wide range of cell types and lacks the disease vectors found in mammalian collagen; ISO13485:2016-certified manufacturing facility.
Differentiation
Value Proposition
Provides a sustainable, non-mammalian 'Collagen Type 0' that offers an evolutionary ancient scaffold for tissue engineering while eliminating mammalian disease transmission risks associated with bovine or porcine sources.
How They Differentiate
Pioneer in non-mammalian biomaterials specifically for bioprinting; uses jellyfish collagen which is chemically simpler and safer than traditional mammalian sources.
Market & Competition
Target Customers
Universities, research laboratories, medical companies, biotech/pharma
Industry Verticals
Regenerative medicine; Tissue engineering; Wound care; Bioprinting; Scientific research
Competitors
CollPlant Biotechnologies (recombinant human collagen for bioprinting), Symatese (medical-grade collagen extraction and transformation), and Regenity (formerly Collagen Solutions, providing medical-grade collagen biomaterials).
Growth & Milestones
Growth Metrics
Turnover estimated £1.3M; Total funding raised >£6.5M.
Major Milestones
Founded in 2013; Launched 7,500 sq ft Cardiff facility in 2017; Achieved ISO13485 certification; Partnered with Copner Biotech in 2021 for bioprinting products; Share allotments in 2024
Notable Customers
Copner Biotech (3D bioprinting partner), Mayo Clinic (clinical development partner), and Thai Union Group (strategic manufacturing and investment partner).